Tehran University of Medical Sciences Acta Medica Iranica 0044-6025 50 2 2012 02 15 79 96 EN Bagher Larijani Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran. Ensieh Nasli Esfahani Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran. Peyvand Amini Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran. Behrouz Nikbin Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran. Kamran Alimoghaddam Hematology-Oncology & BMT Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Somayeh Amiri Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran. Reza Malekzadeh Digestive Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran. Nika Mojahed Yazdi Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran. Maryam Ghodsi Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran. Yahya Dowlati Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran. Mohammad Ali Sahraian Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran. Ardeshir Ghavamzadeh Hematology-Oncology & BMT Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2015 09 28 Stem cells are undifferentiated cells with the ability of proliferation, regeneration, conversion to differentiated cells and producing various tissues. Stem cells are divided into two categories of embryonic and adult. In another categorization stem cells are divided to Totipotent, Multipotent and Unipotent cells. So far usage of stem cells in treatment of various blood diseases has been studied (such as lymphoblastic leukemia, myeloid leukemia, thalassemia, multiple myeloma and cycle cell anemia). In this paper the goal is evaluation of cell therapy in treatment of Parkinson's disease, Amyotrophic lateral sclerosis, Alzheimer, Stroke, Spinal Cord Injury, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Diabetes, Heart Disease, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases. It should be mentioned that some disease that are the target of cell therapy are discussed in this article. https://acta.tums.ac.ir/index.php/acta/article/view/3864 https://acta.tums.ac.ir/index.php/acta/article/download/3864/3839